Co-Diagnostics Inc (CODX)

NASDAQ
Currency in USD
0.690
0.000(0.00%)
Closed
CODX Scorecard
Full Analysis
Holds more cash than debt on its balance sheet
Fair Value
Day's Range
0.6810.720
52 wk Range
0.6502.230
Key Statistics
Edit
Prev. Close
0.69
Open
0.681
Day's Range
0.681-0.72
52 wk Range
0.65-2.23
Volume
82.12K
Average Vol. (3m)
194.73K
1-Year Change
-40.52%
Book Value / Share
2
Fair Value
unlockUnlock
Fair Value Upside
unlockUnlock
CODX Scorecardpro icon
Company’s Health
pro lockUnlock
Fair Value
pro lockUnlock Price
Fair Pricepro lock
Upsidepro lock
Price Target
1.500
Upside
+117.39%
Members' Sentiments
Bearish
Bullish
ProTips
Quickly burning through cash
Show more

Co-Diagnostics Inc Company Profile

Co-Diagnostics, Inc., a molecular diagnostics company, develops, manufactures, and sells reagents used for diagnostic tests that function through the detection and/or analysis of nucleic acid molecules in the United States and internationally. The company offers Co-Dx PCR platform, a polymerase chain reaction (PCR) testing to patients in point-of-care and at-home setting. It also provides PCR diagnostic tests for COVID-19, influenza, tuberculosis, hepatitis B and C, human papillomavirus, malaria, chikungunya, dengue, and the zika virus. In addition, the company offers three multiplexed tests to test mosquitos for the identification of diseases carried by the mosquitos; molecular tools for detection of infectious diseases, liquid biopsy for cancer screening, and agricultural applications; tests that identify genetic traits in plant and animal genomes; and portable diagnostic device designed to bring PCR to patients in point-of-care and at-home settings. The company was incorporated in 2013 and is headquartered in Salt Lake City, Utah.

Compare CODX to Peers and Sector

Metrics to compare
CODX
Peers
Sector
Relationship
P/E Ratio
−0.5x−1.2x−0.7x
PEG Ratio
−0.110.000.00
Price / Book
0.3x1.0x2.6x
Price / LTM Sales
3.0x2.8x3.1x
Upside (Analyst Target)
117.4%91.8%45.9%
Fair Value Upside
Unlock9.7%8.3%Unlock

Analyst Ratings

0 Buy
1 Hold
0 Sell
Ratings:
1 analysts
Overall Consensus
Neutral

Analysts 12-Month Price Target:

Average 1.500
(+117.39% Upside)

Earnings

Latest Release
Nov 07, 2024
EPS / Forecast
-0.32 / -0.33
Revenue / Forecast
641.14K / 375.00K
EPS Revisions
Last 90 days

People Also Watch

87.85
ALAB
-0.39%
1.950
QSI
-3.94%
1.385
AYTU
+0.72%
1.5700
KITT
-6.55%
8.920
RCAT
-5.41%

FAQ

What Is the Co-Diagnostics (CODX) Stock Price Today?

The Co-Diagnostics stock price today is 0.69

What Stock Exchange Does Co-Diagnostics Trade On?

Co-Diagnostics is listed and trades on the NASDAQ stock exchange.

What Is the Stock Symbol for Co-Diagnostics?

The stock symbol for Co-Diagnostics is "CODX."

What Is the Co-Diagnostics Market Cap?

As of today, Co-Diagnostics market cap is 22.02M.

What is Co-Diagnostics Earnings Per Share?

The Co-Diagnostics EPS is -1.38.

What Is the Next Co-Diagnostics Earnings Date?

Co-Diagnostics will release its next earnings report on Apr 08, 2025.

From a Technical Analysis Perspective, Is CODX a Buy or Sell?

Based on moving averages and other technical indicators, the daily buy/sell signal is Strong Sell.
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2025 - Fusion Media Limited. All Rights Reserved.